In-vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum to clinafloxacin, PD 131628, ciprofloxacin and comparator drugs.
Cohen
M A
MA
Huband
M D
MD
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000890:Anti-Infective Agents / Q000494:pharmacology*; D002939:Ciprofloxacin / Q000494:pharmacology*; D002981:Clindamycin / Q000494:pharmacology; D004917:Erythromycin / Q000494:pharmacology; D024841:Fluoroquinolones; D066298:In Vitro Techniques; D008826:Microbial Sensitivity Tests; D019535:Mycoplasma hominis / Q000187:drug effects*; D009177:Mycoplasma pneumoniae / Q000187:drug effects*; D009287:Naphthyridines / Q000494:pharmacology*; D015363:Quinolones / Q000494:pharmacology*; D013752:Tetracycline / Q000494:pharmacology; D016990:Ureaplasma urealyticum / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D009287:Naphthyridines; D015363:Quinolones; C068217:PD 131628; D002981:Clindamycin; D002939:Ciprofloxacin; D004917:Erythromycin; C057477:clinafloxacin; D013752:Tetracycline